Results 211 to 220 of about 10,030,185 (350)

Differences in Longitudinal Health Utility between Stereotactic Body Radiation Therapy and Surgery in Stage I Non–Small Cell Lung Cancer

Journal of Thoracic Oncology, 2018
H. B. Wolff, L. Alberts, E. A. Kastelijn, Birgit I. Lissenberg‐Witte, J. Twisk, F. Lagerwaard, S. Senan, S. E. El Sharouni, F. Schramel, V. Coupé   +9 more
semanticscholar   +1 more source

Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18‐gene panel

Molecular Oncology, EarlyView.
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard, Cristina Mitric, Melanie Care, Tracy L. Stockley, Raymond H. Kim, Jeanna McCuaig, Blaise Clarke, Laura Ranich, Clare Sheen, Sarah E. Ferguson, Liat Hogen, Taymaa May, Marcus Q. Bernardini   +12 more
wiley   +1 more source

Do the Age of Children and Parental Status Matter in Valuing the Child Health Utility 9D (CHU9D)? [PDF]

Pharmacoeconomics
Xiong X, Huang L, Carvalho N, Dalziel K, Devlin N.   +4 more
europepmc   +1 more source

Determinants of health-related quality-of-life in adult survivors of childhood cancer: integrating personal and societal values through a health utility approach. [PDF]

EClinicalMedicine, 2023
Horan MR, Srivastava DK, Bhakta N, Ehrhardt MJ, Brinkman TM, Baker JN, Yasui Y, Krull KR, Ness KK, Robison LL, Hudson MM, Huang IC.   +11 more
europepmc   +1 more source

Using health state utility values from the general population to approximate baselines in decision analytic models when condition specific data are not available [PDF]

Decision analytic models in healthcare require baseline health related quality of life (HRQoL) data to accurately assess the benefits of interventions.
Ara, R, Brazier, JE
core   +1 more source

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

Molecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang, Qian Sun, Daniel Novak, Lei Zhu, Juliane Poelchen, Tamara Steinfass, Yiman Wang, Viktor Umansky, Jochen Utikal   +8 more
wiley   +1 more source

Health Utility Decrement of Injection Treatment-Related Attributes Using Time Trade-Off Among Type 2 Diabetes Patients: A Vignette-Based Study. [PDF]

Pharmacoecon Open
Liu X, Luo C, Xie S, Wu J.
europepmc   +1 more source

The impact of age on health utility values for older women with early-stage breast cancer: a systematic review and meta-regression. [PDF]

Health Qual Life Outcomes, 2022
Wang Y, Gavan SP, Steinke D, Cheung KL, Chen LC.   +4 more
europepmc   +1 more source

Factors associated with health‐related quality of life, hip function, and health utility after operative management of femoral neck fractures

The Bone & Joint Journal, 2018
S. Sprague, M. Bhandari, M. Heetveld, S. Liew, T. Scott, S. Bzovsky, D. Heels-Ansdell, Qi Zhou, M. Swiontkowski, E. Schemitsch   +9 more
semanticscholar   +1 more source

Plasma extrachromosomal circular DNA as a biomarker in EGFR‐targeted therapy of non‐small cell lung cancer

Molecular Oncology, EarlyView.
Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard, Sarmad Mehmood, Eva Boysen Fynboe Ebert, Peter Meldgaard, Anindya Dutta, Boe S. Sorensen   +5 more
wiley   +1 more source